Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 91.220 | 114.950 | 23.730 |
Stocks | 10.190 | 17.760 | 7.570 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.272 | 14.680 |
Price to Book | 1.103 | 1.974 |
Price to Sales | 1.093 | 1.202 |
Price to Cash Flow | 4.990 | 7.702 |
Dividend Yield | 4.370 | 2.737 |
5 Years Earnings Growth | 8.871 | 10.799 |
Name | Net % | Category Average |
---|---|---|
Cash | 90.175 | 54.269 |
Derivative | 0.187 | 36.273 |
Government | -0.730 | 23.393 |
Corporate | 0.179 | 3.110 |
Number of long holdings: 143
Number of short holdings: 95
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Pictet-Short-Term Money Market EUR Z | LU0222474503 | 5.30 | - | - | |
Novo Nordisk B | DK0062498333 | 1.85 | 903.3 | -1.05% | |
Cs1 19.04.24 C35 Call @ 35.000 | FREN19955656 | 1.81 | - | - | |
Compass Group plc - STND OPT Apr. 19, 2024 Call 2300 | GB00C01NZ129 | 1.56 | - | - | |
Novn 19.04.24 C87 Call @ 87.000 | DE000F0L2P85 | 1.42 | - | - | |
CFD on Vodafone Group PLC | - | 1.37 | - | - | |
Eoa 19.04.24 C13 Call @ 13.000 | DE000F0K5W44 | 1.18 | - | - | |
Galderma | CH1335392721 | 0.98 | 73.88 | -1.27% | |
Adyen | NL0012969182 | 0.97 | 1,246.00 | +0.39% | |
Da1 19.04.24 C62 Call @ 62.000 | FREN19870129 | 0.97 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Global Megatrend Selection c | 12.46B | 11.05 | -2.43 | 6.87 | ||
LU1368233612 | 5.4B | 1.00 | -1.95 | - | ||
Pictet Biotech HP CHF | 1.53B | 2.61 | -5.10 | 2.33 | ||
Pictet Hi div Selection I CHF | 920.94M | 1.88 | -3.08 | - | ||
Pictet Hi div Selection I dy CHF | 920.94M | 1.88 | -3.07 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review